Vir Biotechnology

Vir Biotechnology

Vir Biotechnology

Vir brings together cuttingedge innovations with leading scientific expertise and management to take on some of the worlds most challenging infectious diseases for which solutions are nonexistent or inadequate.
Raised
$66M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$66,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees
Pulse 2.0

GlaxoSmithKline Invests $250 Million In Vir Biotechnology As Part Of A Strategic Deal

the home of AI info

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

the home of AI info

Vir Biotechnology Inc. (VIR) and Minerva Neurosciences Inc. (NASDAQ:NERV) Comparison side ...

GeekWire , Xconomy

Shares of Gates-backed Vir Bio tumble after $143M IPO to fund infectious disease efforts